Dennie T. Frederick

2012–2025 年に発表

86
論文数
30,609
被引用数
64
h 指数
85
i10 指数

被引用数

Dennie T. Frederick の年別被引用数1971 年: 被引用 2 件1993 年: 被引用 1 件2003 年: 被引用 3 件2005 年: 被引用 1 件2006 年: 被引用 1 件2011 年: 被引用 3 件2012 年: 被引用 20 件2013 年: 被引用 139 件2014 年: 被引用 290 件2015 年: 被引用 309 件2016 年: 被引用 302 件2017 年: 被引用 481 件2018 年: 被引用 517 件2019 年: 被引用 1,536 件2020 年: 被引用 1,973 件2021 年: 被引用 2,041 件2022 年: 被引用 1,968 件2023 年: 被引用 1,726 件2024 年: 被引用 2,334 件2025 年: 被引用 1,283 件2026 年: 被引用 51 件1972〜1992 年は被引用が無いため表示していません1994〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2007〜2010 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,419 件、この内訳の 29%中国: 引用元論文 3,147 件、この内訳の 16.8%ドイツ: 引用元論文 987 件、この内訳の 5.3%イギリス: 引用元論文 958 件、この内訳の 5.1%イタリア: 引用元論文 718 件、この内訳の 3.8%フランス: 引用元論文 677 件、この内訳の 3.6%オーストラリア: 引用元論文 540 件、この内訳の 2.9%スイス: 引用元論文 511 件、この内訳の 2.7%カナダ: 引用元論文 477 件、この内訳の 2.5%日本: 引用元論文 440 件、この内訳の 2.4%スペイン: 引用元論文 428 件、この内訳の 2.3%オランダ: 引用元論文 421 件、この内訳の 2.3%
0%29%その他 21.3%

分野

  • Biochemistry, Genetics and Molecular Biology43.2%
  • Medicine40.7%
  • Immunology and Microbiology11.7%
  • Engineering1.4%
  • Neuroscience0.9%
  • Computer Science0.5%
  • その他1.6%

トピック

  • Cancer Immunotherapy and Biomarkers9.6%
  • Immunotherapy and Immune Responses5.2%
  • Single-cell and spatial transcriptomics4.9%
  • CAR-T cell therapy research4.1%
  • Immune Cell Function and Interaction4.1%
  • Cancer Genomics and Diagnostics3.6%
  • その他68.5%

共著者

全論文

検索で開く
  1. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennie T. Frederick, Judit Jané‐Valbuena, Charles H. Yoon, Orit Rozenblatt–Rosen, Alex K. Shalek, Aviv Regev, Levi A. Garraway - Science 2016 被引用: 5,391

  2. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer A. Wargo, Genevieve M. Boland, Ryan J. Sullivan, Gad Getz, Nir Hacohen - Cell 2018 被引用: 2,103

  3. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman - Science 2017 被引用: 1,812

  4. Spatially organized multicellular immune hubs in human colorectal cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natasha Asinovski, Tabea Moll, Max N. Goder-Reiser, Anise S. Applebaum, Lauren K. Brais, Laura DelloStritto, Sarah Denning, Susannah Phillips, Emma K. Hill, Julia K. Meehan, Dennie T. Frederick, Tatyana Sharova, Abhay Kanodia, Ellen Todres, Judit Jané‐Valbuena, Moshe Biton, Benjamin Izar, Conner Lambden, Thomas E. Clancy, Ronald Bleday, Nelya Melnitchouk, Jennifer Irani, Hiroko Kunitake, David L. Berger, Amitabh Srivastava, Jason L. Hornick, Shuji Ogino, Asaf Rotem, Sébastien Vigneau, Bruce E. Johnson, Ryan B. Corcoran, Arlene H. Sharpe, Vijay K. Kuchroo, Kimmie Ng, Marios Giannakis, Linda T. Nieman, Genevieve M. Boland, Andrew J. Aguirre, Ana C. Anderson, Orit Rozenblatt–Rosen, Aviv Regev, Nir Hacohen - Cell 2021 被引用: 870

  5. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Israel Cañadas, Bastian Schilling, Adam N.R. Cartwright, Adrienne Luoma, Shruti Malu, Patrick Hwu, Chantale Bernatchez, Marie-Andrée Forget, David A. Barbie, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai W. Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt–Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev - Cell 2018 被引用: 1,482

  6. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 被引用: 555

  7. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy

    著者: , , , , , , , , - Immunity 2019 被引用: 710

  8. Resistance to checkpoint blockade therapy through inactivation of antigen presentation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nir Hacohen - Nature Communications 2017 被引用: 1,001

  9. Toward Minimal Residual Disease-Directed Therapy in Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 被引用: 784

  10. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma

    著者: , , , , , , , , , , , , , - Nature Medicine 2018 被引用: 817

  11. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Samantha Fennessey, Christian Stolte, Federico Gaiti, Giorgio Inghirami, Viktor A. Adalsteinsson, Brian Houck‐Loomis, Jennifer Ishii, Jedd D. Wolchok, Genevieve M. Boland, Nicolas Robine, Nasser K. Altorki, Dan A. Landau - Nature Medicine 2020 被引用: 436

  12. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 被引用: 572

  13. Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth

    著者: , , , , , , , , , , , , , , , , , , - Nature Metabolism 2022 被引用: 161

  14. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nir Hacohen, Kathleen B. Yates, Robert T. Manguso - Nature Immunology 2022 被引用: 222

  15. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

    著者: , , , , , , , , , , , , , , , , , , - Nature 2012 被引用: 1,760

  16. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 被引用: 193

  17. Targeting TBK1 to overcome resistance to cancer immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xingping Qin, Kristopher A. Sarosiek, Gao Zhang, Jong Wook Kim, Mack Y. Su, Angelina M. Cicerchia, Martin Q. Rasmussen, Samuel J. Klempner, Dejan Juric, Sara I. Pai, David M. Miller, Anita Giobbie‐Hurder, Jonathan Chen, Karin Pelka, Dennie T. Frederick, Susanna Stinson, Elena V. Ivanova, Amir Reza Aref, Cloud P. Paweletz, David A. Barbie, Debattama R. Sen, David E. Fisher, Ryan B. Corcoran, Nir Hacohen, Peter K. Sorger, Keith T. Flaherty, Genevieve M. Boland, Robert T. Manguso, Russell W. Jenkins - Nature 2023 被引用: 167

  18. RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qin Liu, Edmund K. Bartlett, Giorgos C. Karakousis, Zeynep Eroglu, Roger S. Lo, Matthew Chan, Alexander M. Menzies, Georgina V. Long, Douglas B. Johnson, Jeffrey A. Sosman, Bastian Schilling, Dirk Schadendorf, David W. Speicher, Marcus Bosenberg, Antoni Ribas, Ashani T. Weeraratna - Nature 2016 被引用: 390

  19. Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF

    著者: , , , , , , , , , , , , , , - Cancer Cell 2013 被引用: 815

  20. The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona - Nature Genetics 2015 被引用: 553

  21. Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Douglas B. Johnson, Ryan J. Sullivan, Genevieve M. Boland - Clinical Cancer Research 2021 被引用: 176

  22. HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 84

  23. Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 被引用: 153

  24. Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennie T. Frederick, Wendie Den Brok, Caroline Lohrisch, Tamara Shenkier, Christine Simmons, Diego Villa, Andrew J. Mungall, Richard A. Moore, Elena Zaikova, Viviana Cerda, Esther Kong, Daniel Lai, Murtaza Malbari, Melissa Marton, Dina Manaa, Lara Winterkorn, Karen A. Gelmon, Margaret K. Callahan, Genevieve M. Boland, Catherine Potenski, Jedd D. Wolchok, Ashish Saxena, Samra Turajlic, Marcin Imieliński, Michael F. Berger, Samuel Aparício, Nasser K. Altorki, Michael A. Postow, Nicolas Robine, Claus L. Andersen, Dan A. Landau - Nature Medicine 2024 被引用: 99